Novavax (NVAX)

Novavax (NVAX) Stock Price & Analysis


NVAX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.61 - $25.66
Previous Close$6.81
Average Volume (3M)9.16M
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$516.27M
Total Debt (Recent Filing)$198.94M
Price to Earnings (P/E)-0.9
Nov 02, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.27
Shares Outstanding94,404,185
10 Day Avg. Volume12,060,415
30 Day Avg. Volume9,157,224
Standard Deviation0.42
Financial Highlights & Ratios
Price to Book (P/B)-0.75
Price to Sales (P/S)1.51
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside236.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Novavax’s price range in the past 12 months?
Novavax lowest stock price was $5.61 and its highest was $25.66 in the past 12 months.
    What is Novavax’s market cap?
    Currently, no data Available
    When is Novavax’s upcoming earnings report date?
    Novavax’s upcoming earnings report date is Nov 02, 2023 which is in 41 days.
      How were Novavax’s earnings last quarter?
      Novavax released its earnings results on Aug 08, 2023. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of -$1.332 by $1.912.
        Is Novavax overvalued?
        According to Wall Street analysts Novavax’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Novavax pay dividends?
          Novavax does not currently pay dividends.
          What is Novavax’s EPS estimate?
          Novavax’s EPS estimate is -$1.33.
            How many shares outstanding does Novavax have?
            Novavax has 94,404,180 shares outstanding.
              What happened to Novavax’s price movement after its last earnings report?
              Novavax reported an EPS of $0.58 in its last earnings report, beating expectations of -$1.332. Following the earnings report the stock price went down -3.856%.
                Which hedge fund is a major shareholder of Novavax?
                Among the largest hedge funds holding Novavax’s share is Coatue Management, LLC. It holds Novavax’s shares valued at 8M.


                  Novavax Stock Smart Score

                  The Novavax stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Novavax, Inc. is a late-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It produces vaccine candidates to respond to both known and emerging disease threats by using the proprietary recombinant nanoparticle vaccine technology. Its vaccine candidates include ResVax and NanoFlu. It also develops immune stimulating saponin-based adjuvants through its wholly owned Swedish subsidiary, Novavax AB. The company was founded in 1987 and is headquartered in Gaithersburg, MD.


                  Top 5 ETFs holding NVAX

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity Nasdaq Composite Index ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold NVAX. The ETFs are listed according to market value of NVAX within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Inovio Pharmaceuticals
                  BioNTech SE

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis